Workflow
Central Nervous System (CNS) portfolio expansion
icon
搜索文档
Dr Reddy’s shares slip nearly 2% on investor concerns amid $50 million foray into anti-vertigo category
The Economic Times· 2025-09-11 12:00
The transaction covers 18 markets across APAC and EMEA, with India and Vietnam identified as focus geographies. Stugeron, which contains the antihistamine Cinnarizine, is prescribed for vestibular disorders and vertigo.In India, the brand leads the Cinnarizine-represented pharmaceutical market (RPM) and ranks second in the broader anti-vertigo represented pharmaceutical market (eRPM). The deal will help Dr. Reddy’s strengthen its Central Nervous System (CNS) portfolio and expand in the anti-vertigo space.“ ...